<p><strong>CVS Health Co.</strong> (NYSE:CVS - 获取免费报告) 于 3 月 20 日（星期四）宣布了季度股息，RTT News 报道称。4 月 22 日（星期二）登记的投资者将在 5 月 1 日（星期四）获得每股 0.665 的股息。这相当于年化股息 2.66 美元，收益率为 3.89%。</p>
<ul>
<li>Walgreens Boots Alliance：不要轻视这个资产冠军</li>
</ul>
<p>CVS Health 在过去三年中平均每年提高股息 10.0%。CVS Health 的派息比率为 38.8%，表明其股息得到了足够的盈利支持。股票研究分析师预计 CVS Health 明年的每股收益为 6.77 美元，这意味着公司应该能够继续覆盖其 2.66 美元的年股息，预计未来的派息比率为 39.3%。</p>
<h2>CVS Health 股票上涨 0.8%</h2>
<p>CVS 股票在星期四上涨 0.55 美元，达到 68.46 美元。该股票交易量为 2,210,006 股，而其平均交易量为 11,031,100 股。该公司的流动比率为 0.81，速动比率为 0.60，债务与股本比率为 0.80。该公司的市值为 863.2 亿美元，市盈率为 18.71，市盈增长比率为 0.98，贝塔值为 0.54。该公司 50 日移动平均线为 59.76 美元，200 日移动平均线为 57.20 美元。CVS Health 的 52 周低点为 43.56 美元，52 周高点为 80.75 美元。</p>
<ul>
<li>2025 年三只受挫的医疗股复苏</li>
</ul>
<p>CVS Health (NYSE:CVS - 获取免费报告) 最近一次发布季度财报是在 2 月 12 日（星期三）。该药房运营商报告季度每股收益为 1.19 美元，超出市场共识预期的 0.89 美元，超出幅度为 0.30 美元。CVS Health 的股本回报率为 9.11%，净利润率为 1.24%。股票分析师预计 CVS Health 今年的每股收益为 5.89 美元。</p>
<h2>华尔街分析师观点</h2>
<p>CVS 最近成为多份分析报告的主题。TD Cowen 在 11 月 25 日（星期一）的研究报告中将 CVS Health 的目标价从 73.00 美元上调至 80.00 美元，并给予该公司 “买入” 评级。德意志银行将 CVS Health 的评级从 “持有” 上调至 “买入”，并在 12 月 3 日（星期二）的研究报告中设定了 66.00 美元的目标价。Argus 在 2 月 18 日（星期二）的研究报告中设定了 CVS Health 的目标价为 77.00 美元。富国银行在 2 月 13 日（星期四）的研究报告中将 CVS Health 的目标价从 68.00 美元上调至 73.00 美元，并给予该股票 “增持” 评级。最后，Cantor Fitzgerald 在 2 月 12 日（星期三）的研究报告中将 CVS Health 的评级从 “中性” 上调至 “增持”。四位研究分析师对该股票给予 “持有” 评级，十七位给予 “买入” 评级，一位给予 “强烈买入” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，平均目标价为 69.83 美元。</p>
<ul>
<li>Humana 尽管在医疗保险优势上遭遇损失仍获利——有什么隐情？</li>
</ul>
<p><strong>获取我们最新的 CVS 股票分析</strong></p>
<h2>CVS Health 的内部交易</h2>
<p>在其他新闻中，董事 Michael F. Mahoney 在 2 月 18 日（星期二）购买了 30,000 股该公司的股票。该股票的平均购买成本为每股 66.70 美元，总价值为 2,001,000.00 美元。交易完成后，该董事现在直接持有 39,356 股公司股票，价值约为 2,625,045.20 美元。这代表其持股增加了 320.65%。该购买在向证券交易委员会的备案中披露，相关信息可以通过此链接访问。此外，SVP James David Clark 在 3 月 5 日（星期三）出售了 7,513 股公司的股票。该股票的平均售价为 66.35 美元，总价值为 498,487.55 美元。交易完成后，该高级副总裁现在直接持有 8,394 股公司的股票，价值为 556,941.90 美元。这笔交易使其持股减少了 47.23%。该出售的披露信息可以在这里找到。公司内部人士持有该公司 0.24% 的股份。</p>
<h2>CVS Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>在哪里可以找到财报电话会议记录</li>
<li>关于亚马逊股票的一切信号都表明买入——是时候加仓了吗？</li>
<li>什么是股息收割策略，投资者如何从中获利？</li>
<li>五个理由说明 Five Below 的股价今年将上涨</li>
<li>什么是股息之王？</li>
<li>博通：为什么这只芯片股票仍然是长期人工智能投资的首选</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/DividendChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/DividendChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西维斯

<p>CVS Health Co.（纽约证券交易所代码：CVS）宣布季度股息为 0.67 美元，将于 5 月 1 日支付给截至 4 月 22 日的股东。这年化股息为 2.66 美元，收益率为 3.89%。在过去三年中，公司平均每年增加股息 10%，派息比率为 38.8%。CVS 股票上涨 0.8%，至 68.46 美元，分析师预计明年的每股收益为 6.77 美元。最近的分析师评级显示共识为 “适度买入”，平均目标价为 69.83 美元</p>

<p><strong>CVS Health Co.</strong> (NYSE:CVS - Get Free Report) announced a quarterly dividend on Thursday, March 20th, RTT News reports. Investors of record on Tuesday, April 22nd will be given a dividend of 0.665 per share by the pharmacy operator on Thursday, May 1st. This represents a $2.66 dividend on an annualized basis and a yield of 3.89%.</p>
<div class="lb-trans"><p><strong>CVS Health Co.</strong> (NYSE:CVS - 获取免费报告) 于 3 月 20 日（星期四）宣布了季度股息，RTT News 报道称。4 月 22 日（星期二）登记的投资者将在 5 月 1 日（星期四）获得每股 0.665 的股息。这相当于年化股息 2.66 美元，收益率为 3.89%。</p>
</div><ul>
<li>Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet</li>
</ul>
<div class="lb-trans"><ul>
<li>Walgreens Boots Alliance：不要轻视这个资产冠军</li>
</ul>
</div><p>CVS Health has raised its dividend by an average of 10.0% per year over the last three years. CVS Health has a payout ratio of 38.8% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect CVS Health to earn $6.77 per share next year, which means the company should continue to be able to cover its $2.66 annual dividend with an expected future payout ratio of 39.3%.</p>
<div class="lb-trans"><p>CVS Health 在过去三年中平均每年提高股息 10.0%。CVS Health 的派息比率为 38.8%，表明其股息得到了足够的盈利支持。股票研究分析师预计 CVS Health 明年的每股收益为 6.77 美元，这意味着公司应该能够继续覆盖其 2.66 美元的年股息，预计未来的派息比率为 39.3%。</p>
</div><h2>CVS Health Stock Up 0.8 %</h2>
<div class="lb-trans"><h2>CVS Health 股票上涨 0.8%</h2>
</div><p>Shares of CVS stock traded up $0.55 on Thursday, hitting $68.46. 2,210,006 shares of the stock were exchanged, compared to its average volume of 11,031,100. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $86.32 billion, a P/E ratio of 18.71, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The business has a 50-day moving average of $59.76 and a 200 day moving average of $57.20. CVS Health has a fifty-two week low of $43.56 and a fifty-two week high of $80.75.</p>
<div class="lb-trans"><p>CVS 股票在星期四上涨 0.55 美元，达到 68.46 美元。该股票交易量为 2,210,006 股，而其平均交易量为 11,031,100 股。该公司的流动比率为 0.81，速动比率为 0.60，债务与股本比率为 0.80。该公司的市值为 863.2 亿美元，市盈率为 18.71，市盈增长比率为 0.98，贝塔值为 0.54。该公司 50 日移动平均线为 59.76 美元，200 日移动平均线为 57.20 美元。CVS Health 的 52 周低点为 43.56 美元，52 周高点为 80.75 美元。</p>
</div><ul>
<li>3 Beaten Down Healthcare Stocks Recovering in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>2025 年三只受挫的医疗股复苏</li>
</ul>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Equities analysts anticipate that CVS Health will post 5.89 EPS for the current year.</p>
<div class="lb-trans"><p>CVS Health (NYSE:CVS - 获取免费报告) 最近一次发布季度财报是在 2 月 12 日（星期三）。该药房运营商报告季度每股收益为 1.19 美元，超出市场共识预期的 0.89 美元，超出幅度为 0.30 美元。CVS Health 的股本回报率为 9.11%，净利润率为 1.24%。股票分析师预计 CVS Health 今年的每股收益为 5.89 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>CVS has been the subject of a number of recent analyst reports. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the company a &#34;buy&#34; rating in a research report on Monday, November 25th. Deutsche Bank Aktiengesellschaft raised CVS Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating and set a $66.00 price objective for the company in a research report on Tuesday, December 3rd. Argus set a $77.00 price objective on CVS Health in a research report on Tuesday, February 18th. Wells Fargo &amp; Company increased their target price on CVS Health from $68.00 to $73.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday, February 13th. Finally, Cantor Fitzgerald upgraded CVS Health from a &#34;neutral&#34; rating to an &#34;overweight&#34; rating in a research note on Wednesday, February 12th. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $69.83.</p>
<div class="lb-trans"><p>CVS 最近成为多份分析报告的主题。TD Cowen 在 11 月 25 日（星期一）的研究报告中将 CVS Health 的目标价从 73.00 美元上调至 80.00 美元，并给予该公司 “买入” 评级。德意志银行将 CVS Health 的评级从 “持有” 上调至 “买入”，并在 12 月 3 日（星期二）的研究报告中设定了 66.00 美元的目标价。Argus 在 2 月 18 日（星期二）的研究报告中设定了 CVS Health 的目标价为 77.00 美元。富国银行在 2 月 13 日（星期四）的研究报告中将 CVS Health 的目标价从 68.00 美元上调至 73.00 美元，并给予该股票 “增持” 评级。最后，Cantor Fitzgerald 在 2 月 12 日（星期三）的研究报告中将 CVS Health 的评级从 “中性” 上调至 “增持”。四位研究分析师对该股票给予 “持有” 评级，十七位给予 “买入” 评级，一位给予 “强烈买入” 评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，平均目标价为 69.83 美元。</p>
</div><ul>
<li>Humana Gains Despite Medicare Advantage Losses—What’s the Catch?</li>
</ul>
<div class="lb-trans"><ul>
<li>Humana 尽管在医疗保险优势上遭遇损失仍获利——有什么隐情？</li>
</ul>
</div><p><strong>Get Our Latest Stock Analysis on CVS</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 CVS 股票分析</strong></p>
</div><h2>Insider Transactions at CVS Health</h2>
<div class="lb-trans"><h2>CVS Health 的内部交易</h2>
</div><p>In other news, Director Michael F. Mahoney bought 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The stock was acquired at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now directly owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, SVP James David Clark sold 7,513 shares of the business's stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares of the company's stock, valued at $556,941.90. The trade was a 47.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.24% of the company's stock.</p>
<div class="lb-trans"><p>在其他新闻中，董事 Michael F. Mahoney 在 2 月 18 日（星期二）购买了 30,000 股该公司的股票。该股票的平均购买成本为每股 66.70 美元，总价值为 2,001,000.00 美元。交易完成后，该董事现在直接持有 39,356 股公司股票，价值约为 2,625,045.20 美元。这代表其持股增加了 320.65%。该购买在向证券交易委员会的备案中披露，相关信息可以通过此链接访问。此外，SVP James David Clark 在 3 月 5 日（星期三）出售了 7,513 股公司的股票。该股票的平均售价为 66.35 美元，总价值为 498,487.55 美元。交易完成后，该高级副总裁现在直接持有 8,394 股公司的股票，价值为 556,941.90 美元。这笔交易使其持股减少了 47.23%。该出售的披露信息可以在这里找到。公司内部人士持有该公司 0.24% 的股份。</p>
</div><h2>CVS Health Company Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy &amp; Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p>
<div class="lb-trans"><p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>Where to Find Earnings Call Transcripts</li>
<li>Everything About Amazon Stock Signals a Buy—Time to Load Up?</li>
<li>What is a Dividend Harvesting Strategy and How Can Investors Profit from it?</li>
<li>5 Reasons Five Below’s Stock Price Is Heading Higher This Year</li>
<li>What is a Dividend King?</li>
<li>Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>在哪里可以找到财报电话会议记录</li>
<li>关于亚马逊股票的一切信号都表明买入——是时候加仓了吗？</li>
<li>什么是股息收割策略，投资者如何从中获利？</li>
<li>五个理由说明 Five Below 的股价今年将上涨</li>
<li>什么是股息之王？</li>
<li>博通：为什么这只芯片股票仍然是长期人工智能投资的首选</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/DividendChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/DividendChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买……而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得 “适度买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

西维斯公司（纽约证券交易所代码：CVS）宣布季度股息为 $0.67